Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin C  COVID-19 treatment studies for Vitamin C  C19 studies: Vitamin C  Vitamin C   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Evaluation of the Clinical Effects of an Antiviral, Immunostimulant and Antioxidant Phytotherapy in Patients Suffering from COVID-19 Infection: An Observational Pilot Study
Ortore et al., International Journal of Translational Medicine, doi:10.3390/ijtm2020022
Ortore et al., Evaluation of the Clinical Effects of an Antiviral, Immunostimulant and Antioxidant Phytotherapy in Patients.., International Journal of Translational Medicine, doi:10.3390/ijtm2020022
Jun 2022   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective case series of 240 patients in Italy in 2020, up to 96 years old, showing no mortality and 1.6% hospitalization with early treatment including vitamin C, quercetin, and green tea and red wine polyphenols.
The formulation was based on SARS-CoV-2 molecular docking studies. Low bioavailability is a known issue for polyphenols. Authors note that bioavailability may be improved with combinations of polyphenols which may have a synergistic effect, and via consumption with dietary fat.
Ortore et al., 16 Jun 2022, Italy, peer-reviewed, 12 authors, study period September 2020 - December 2021.
Contact: eliana.tranchita@gmail.com (corresponding author), ortore.massimiliano@libero.it, alessiamanteca@yahoo.it, sinerfitonlus@gmail.com, iginofabi@libero.it, antonella.foti2010@libero.it, giovanna.borriello@gmail.com, paoloriondino@gmail.com, elisa.grazioli@uniroma4.it, carlo.minganti@uniroma4.it, claudia.cerulli@uniroma4.it, attilio.parisi@uniroma4.it.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin CAll
Abstract: Article Evaluation of the Clinical Effects of an Antiviral, Immunostimulant and Antioxidant Phytotherapy in Patients Suffering from COVID-19 Infection: An Observational Pilot Study Massimiliano Ortore 1 , Elisa Grazioli 2,3 , Eliana Tranchita 2, *, Carlo Minganti 2 , Alessia Manteca 1 , Ludovico Tinto 1 , Claudia Cerulli 2 , Igino Fabi 1 , Antonella Foti 1 , Giovanna Borriello 1 , Paolo Riondino 1 and Attilio Parisi 2 1 2 3 * Citation: Ortore, M.; Grazioli, E.; Tranchita, E.; Minganti, C.; Manteca, A.; Tinto, L.; Cerulli, C.; Fabi, I.; Foti, A.; Borriello, G.; et al. Evaluation of the Clinical Effects of an Antiviral, Immunostimulant and Antioxidant Phytotherapy in Patients Suffering from COVID-19 Infection: An Observational Pilot Study. Int. J. Transl. Med. 2022, 2, 242–251. https://doi.org/10.3390/ijtm2020022 Academic Editor: Bernhard Ryffel Received: 5 May 2022 Accepted: 14 June 2022 Published: 16 June 2022 Publisher’s Note: MDPI stays neutral Associazione Sinerfit, 00199 Rome, Italy; ortore.massimiliano@libero.it (M.O.); alessiamanteca@yahoo.it (A.M.); sinerfitonlus@gmail.com (L.T.); iginofabi@libero.it (I.F.); antonella.foti2010@libero.it (A.F.); giovanna.borriello@gmail.com (G.B.); paoloriondino@gmail.com (P.R.) Department of Movement, Human and Health Sciences, University of Rome “Foro Italico”, 00135 Rome, Italy; elisa.grazioli@uniroma4.it (E.G.); carlo.minganti@uniroma4.it (C.M.); claudia.cerulli@uniroma4.it (C.C.); attilio.parisi@uniroma4.it (A.P.) Department of Experimental and Clinical Medicine, “Magna Graecia” University, 88100 Catanzaro, Italy Correspondence: eliana.tranchita@gmail.com; Tel.: +39-0636733333 Abstract: Background: In the last two years, the COVID-19 pandemic has spread all over the world, affecting millions of people. The same infection can manifest in different clinical conditions, ranging from mild situations to severe patient impairment, up to their death. The COVID-19 infection can activate innate and adaptive immune systems and cause massive inflammatory responses that is important to treat as soon as possible. Methods: In the initial phase of the pandemic, a group of 240 unvaccinated subjects with COVID-19 disease was administered phytotherapy with immunostimulant and antioxidant property to evaluate the role of this phytotherapeutic preparation in counteracting the progression of the COVID-19 disease both in duration and complexity. Results: 161 patients were treated with phytotherapy alone and the prevailing symptoms in the acute phase were rhinitis, fever, cough, osteo-muscular pains; the other 79 patients were given a therapy with NSAIDs, symptomatic drugs, monoclonal antibodies, corticosteroids, antibiotics, and/or heparin. The coexistence of comorbidity (such as diabetes, hypertension, gastro-intestinal disease) was recorded in 74 out of 240 subjects, more frequently in the older subjects; there was no statistically significant correlation between the presence of comorbidity and the duration of disease. Hospitalization rate in this population was 1.6% and lethality rate was 0%. Conclusion: The use of phytotherapy can represent a valid weapon against COVID-19, since it showed no side effects and can also be used in association with other pharmacological therapies to reduce the massive inflammatory responses of this infection. Keywords: population health; infectious diseases; phytotherapy with regard to jurisdictional claims in published maps and institutional affiliations. 1...
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit